Salud financiera de hoja de balance de Edwards Lifesciences
Salud financiera controles de criterios 6/6
Edwards Lifesciences tiene un patrimonio de accionistas total de $9.6B y una deuda total de $597.5M, lo que sitúa su ratio deuda-patrimonio en 6.2%. Sus activos y pasivos totales son $13.0B y $3.4B respectivamente. El BAIT de Edwards Lifesciences es de $1.9B, por lo que su ratio de cobertura de intereses es de -28.5. Tiene efectivo e inversiones a corto plazo que ascienden a $4.4B.
Información clave
6.2%
Ratio deuda-patrimonio
US$597.50m
Deuda
| Ratio de cobertura de intereses | -28.5x |
| Efectivo | US$4.45b |
| Patrimonio | US$9.61b |
| Total pasivo | US$3.36b |
| Activos totales | US$12.97b |
Actualizaciones recientes sobre salud financiera
Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Jun 24
Here's Why Edwards Lifesciences (NYSE:EW) Can Manage Its Debt Responsibly
Jan 28Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Oct 23Recent updates
Estimating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Nov 11Edwards Lifesciences Q3: Divesting Critical Care And Focusing On Structural Hearts
Oct 25Bearish: Analysts Just Cut Their Edwards Lifesciences Corporation (NYSE:EW) Revenue and EPS estimates
Sep 11Capital Investments At Edwards Lifesciences (NYSE:EW) Point To A Promising Future
Aug 30Is Now The Time To Look At Buying Edwards Lifesciences Corporation (NYSE:EW)?
Aug 17Edwards Lifesciences Q2: Buy The Dip Amid Guidance Cut
Jul 26Calculating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Jul 26Why Investors Shouldn't Be Surprised By Edwards Lifesciences Corporation's (NYSE:EW) P/E
Jul 12Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Jun 24Edwards Lifesciences Corp Looks Bullish (Technical Analysis)
Jun 22Capital Investments At Edwards Lifesciences (NYSE:EW) Point To A Promising Future
May 13Edwards Lifesciences: EPS Acceleration, Shares Poised To Rally (Rating Upgrade)
May 09When Should You Buy Edwards Lifesciences Corporation (NYSE:EW)?
Apr 29Calculating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Apr 15Edwards Lifesciences Corporation's (NYSE:EW) Popularity With Investors Is Clear
Apr 01Edwards Lifesciences' (NYSE:EW) Soft Earnings Don't Show The Whole Picture
Feb 21Edwards Lifesciences: EVOQUE FDA Approval; Critical Care Spin-Off (Rating Maintained)
Feb 14Edwards Lifesciences Corporation (NYSE:EW) Released Earnings Last Week And Analysts Lifted Their Price Target To US$90.47
Feb 08Here's Why Edwards Lifesciences (NYSE:EW) Can Manage Its Debt Responsibly
Jan 28The Returns At Edwards Lifesciences (NYSE:EW) Aren't Growing
Jan 14Edwards Lifesciences: Undervalued With A Substantial Upside Potential
Jan 09Edwards Lifesciences Corporation's (NYSE:EW) Share Price Not Quite Adding Up
Dec 31Calculating The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)
Dec 17Edwards Lifesciences: Sector Derating A Bigger Threat Than Competition Or Slowing Markets
Oct 26Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Oct 23Is Now The Time To Look At Buying Edwards Lifesciences Corporation (NYSE:EW)?
Oct 09Edwards Lifesciences (NYSE:EW) Is Reinvesting To Multiply In Value
Sep 26A Look At The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Sep 11Edwards Lifesciences: Rising Dominance In Structural Heart Disease
Aug 21Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo ($6.7B) de EW superan a sus pasivos a corto plazo ($1.9B).
Pasivo a largo plazo: Los activos a corto plazo de EW ($6.7B) superan a sus pasivos a largo plazo ($1.4B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: EW tiene más efectivo que su deuda total.
Reducción de la deuda: El ratio deuda-patrimonio de EW ha pasado de 15.6% a 6.2% en los últimos 5 años.
Cobertura de la deuda: La deuda de EW está bien cubierta por el flujo de caja operativo (135%).
Cobertura de intereses: EW gana más intereses de los que paga, por lo que la cobertura de pagos de intereses no es preocupante.